These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7899579)

  • 1. Protection against cisplatin lethality and renal toxicity by chlorpromazine in mice.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Ren Fail; 1994 Nov; 16(6):681-6. PubMed ID: 7899579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection by chlorpromazine against lethality and renal toxicity of cisplatin in mice.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Experientia; 1992 Dec; 48(11-12):1142-4. PubMed ID: 1473580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interaction effects on antitumor drugs. XIII. Amelioration of cisplatin lethality and renal toxicity by chlorpromazine in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Biol Pharm Bull; 1993 Nov; 16(11):1104-7. PubMed ID: 8312864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin.
    Wagner T; Kreft B; Bohlmann G; Schwieder G
    J Cancer Res Clin Oncol; 1988; 114(5):497-501. PubMed ID: 3141427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of diabetes on biodistribution, nephrotoxicity and antitumor activity of cisplatin in mice.
    da Silva Faria MC; Santos NA; Carvalho Rodrigues MA; Rodrigues JL; Barbosa Junior F; Santos AC
    Chem Biol Interact; 2015 Mar; 229():119-31. PubMed ID: 25665769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A H 2 S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice.
    Liu M; Jia Z; Sun Y; Zhang A; Yang T
    Mediators Inflamm; 2016; 2016():8145785. PubMed ID: 27340345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug.
    Zunino F; Pratesi G; Micheloni A; Cavalletti E; Sala F; Tofanetti O
    Chem Biol Interact; 1989; 70(1-2):89-101. PubMed ID: 2736678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of NADPH oxidase protects against cisplatin induced nephrotoxicity in mice by two step mechanism.
    Wang Y; Luo X; Pan H; Huang W; Wang X; Wen H; Shen K; Jin B
    Food Chem Toxicol; 2015 Sep; 83():251-60. PubMed ID: 26032634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radio-and chemotoxicity in mice during hypothermia.
    Lundgren-Eriksson L; Palm A; Ryd W; Warnhammar E; Hultborn R
    Anticancer Res; 2001; 21(5):3269-74. PubMed ID: 11848482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of cisplatin-induced nephrotoxicity by cystone, a polyherbal ayurvedic preparation, in C57BL/6J mice bearing B16F1 melanoma without reducing its antitumor activity.
    Rao M; Praveen Rao PN; Kamath R; Rao MN
    J Ethnopharmacol; 1999 Dec; 68(1-3):77-81. PubMed ID: 10624865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice.
    Pan H; Chen J; Shen K; Wang X; Wang P; Fu G; Meng H; Wang Y; Jin B
    PLoS One; 2015; 10(4):e0124775. PubMed ID: 25875356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of reduced glutathione against cis-dichlorodiammine platinum (II)-induced nephrotoxicity and lethal toxicity.
    Zunino F; Tofanetti O; Besati A; Cavalletti E; Savi G
    Tumori; 1983 Apr; 69(2):105-11. PubMed ID: 6683012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of cisplatin toxicity and lethality by juzen-taiho-to in mice.
    Sugiyama K; Ueda H; Ichio Y; Yokota M
    Biol Pharm Bull; 1995 Jan; 18(1):53-8. PubMed ID: 7735251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of cisplatin-induced nephrotoxicity by extracts of Hemidesmus indicus and Acorus calamus.
    Sandeep D; Krishnan Nair CK
    Pharm Biol; 2010 Mar; 48(3):290-5. PubMed ID: 20645815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of zinc glycyrrhizate on toxicity and anticancer activity of cisplatin in mice].
    Xu ZL; Guo JH; Song ST; Li MJ; Wu DZ
    Yao Xue Xue Bao; 1993; 28(8):567-71. PubMed ID: 8285063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental modification of the nephro- and gastroenterotoxicity of cisplatin].
    Kulik GI; Chekhun VF; Pel'kis FP; Boĭm TM
    Vopr Onkol; 1988; 34(12):1477-81. PubMed ID: 3218150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin nephrotoxicity: a review.
    Yao X; Panichpisal K; Kurtzman N; Nugent K
    Am J Med Sci; 2007 Aug; 334(2):115-24. PubMed ID: 17700201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity.
    Arita M; Watanabe S; Aoki N; Kuwahara S; Suzuki R; Goto S; Abe Y; Takahashi M; Sato M; Hokari S; Ohtsubo A; Shoji S; Nozaki K; Ichikawa K; Kondo R; Hayashi M; Ohshima Y; Kabasawa H; Hosojima M; Koya T; Saito A; Kikuchi T
    Sci Rep; 2021 Jan; 11(1):750. PubMed ID: 33437029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
    Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of metallothionein in renal toxicity of cisplatinum.
    Satoh M; Aoki Y; Tohyama C
    Cancer Chemother Pharmacol; 1997; 40(4):358-62. PubMed ID: 9225956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.